India CDMO Market Overview
Base Year: 2024
Forecast Years: 2025–2033
Historical Years: 2019–2024
Market Size in 2024: USD 7.9 Billion
Market Forecast in 2033: USD 15.4 Billion
Market Growth Rate: 7.7% (2025–2033)
The India CDMO market is experiencing robust growth, driven by increasing demand for contract manufacturing services in pharmaceuticals, particularly for complex generics, HPAPIs, and sterile injectables. Indian CDMOs are expanding their global footprint, catering to markets like the U.S., Europe, and emerging economies, thereby creating a positive market outlook.
India CDMO Market Trends and Drivers:
The India CDMO market is booming. Some of the major reasons for its growth include the increased demand for contract manufacturing services in pharmaceuticals as advanced generics, highly potent active pharmaceutical ingredients (HPAPIs), and sterile injectables-which require specific manufacturing capabilities that can be more cost-effective and efficient if outsourced to expert CDMOs. An example is India, with established infrastructure and skills, making it a feasible site for global pharmaceutical companies demanding high-quality manufacturing solutions at competitive prices. This fact has placed Indian CDMOs as critical players in the international and local markets, notably the U.S., Europe, and other emerging economies.
Besides the demand for specialized services, India’s sound regulatory framework contributes significantly to the growth of the CDMO market. As per the high-quality standards, India is also compliant with the international Good Manufacturing Practices (GMP) and regulatory requirements; hence, this results in making the country an appealing destination for pharmaceutical outsourcing. Increasingly, Indian CDMOs are becoming known internationally for meeting the stringent requirements of regulatory agencies, especially in the fields of the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). In addition to this regulatory strength, Indian manufacturers can also widen their footprints globally, furthering market market-positive outlook.
The growing emphasis on cost-efficient strategies in the pharmaceutical spectrum is largely contributing to the market growth of India concerning CDMO. They are giving importance to outsourcing their manufacturing to some of the economically best countries, focusing on India, for their reduced production cost, along with high-quality standards and efficiency. This would make the pharmaceutical house concentrate on areas like R&D, marketing, and distribution while letting an outsourcing company engage in the specifics of production.
Thus, the increase in demand for outsourcing pharmaceutical production is going to result in sustained growth for the CDMO market in India, as companies would be expanding their service offerings and capabilities to meet such increasing demands within the global pharmaceutical industry over the years.
India CDMO Market Report Segmentation:
The report provides an analysis of the key trends in each segment of the market, including India CDMO market size, along with forecasts at the country level for 2025–2033. Our report has categorized the market based on service type, type, scale of operation, therapeutic area, and region.
Service Type Insights:
- API Manufacturing
- Formulation Development
- Fill & Finish Services
- Packaging
- Others
Type Insights:
- Small Molecules
- Biologics
- Others
Scale of Operation Insights:
- Large Scale
- Mid Scale
- Small Scale
Therapeutic Area Insights:
- Oncology
- Cardiovascular
- Neurology
- Others
Regional Insights:
- North India
- West and Central India
- South India
- East India
For an in-depth analysis, you can refer to a sample copy of the report:
https://www.imarcgroup.com/india-cdmo-market/requestsample
Competitive Landscape
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Key Highlights of the Report:
- Market Performance (2019–2024)
- Market Outlook (2025–2033)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Historical, Current, and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note:
If you need specific information that is not currently within the scope of the report, we can provide it as part of the customization.
About Us:
IMARC Group is a leading market research company offering management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic, and technological developments for pharmaceutical, industrial, and high-technology business leaders. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St,Brooklyn, NY 11249, USA
Email: [email protected]
Tel No: (D) +91 120 433 0800
United States: +1-631-791-1145